Downstream effector pathways

Downstream effector pathways are complex networks of intracellular signaling molecules that transmit signals from activated cell surface receptors to specific cellular targets, such as the nucleus or metabolic machinery (Source: Alberts B, et al. Molecular Biology of the Cell, 2014). These pathways, including the MAPK/ERK, PI3K/Akt, and JAK/STAT cascades, regulate fundamental biological processes such as cell growth, survival, and differentiation (Source: Nature Reviews Molecular Cell Biology, 2020). In many pathological states, particularly oncology and immunology, these pathways are frequently hijacked or mutated, leading to uncontrolled cellular proliferation or chronic inflammation (Source: Hanahan D, Weinberg RA. Cell, 2011). While the term refers to a broad category rather than a single molecular entity, the individual components within these pathways serve as critical therapeutic targets for a wide range of small molecule inhibitors and monoclonal antibodies (Source: Janku F, et al. Nature Reviews Clinical Oncology, 2018). Targeting these pathways requires a deep understanding of pathway crosstalk and feedback mechanisms, as the inhibition of one node can often lead to the compensatory activation of another (Source: Pharmacological Reviews, 2021). Consequently, therapeutic strategies often involve combination therapies to achieve more complete pathway blockade and overcome drug resistance (Source: Cancer Discovery, 2019).

Other names

Signaling cascadesIntracellular signaling pathwaysEffector cascadesSignal transduction pathwaysIntracellular signaling networks

Inhibition of specific intracellular signaling nodes, such as kinases or transcription factors, to disrupt the transmission of oncogenic or inflammatory signals from the cell surface to the nucleus (Source: Nature Reviews Drug Discovery, 2018).